Connor, Clark & Lunn Investment Management (CC&L)’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,814
Closed -$420K 1655
2025
Q1
$420K Sell
31,814
-273,825
-90% -$3.61M ﹤0.01% 1183
2024
Q4
$4.83M Sell
305,639
-471,766
-61% -$7.45M 0.02% 491
2024
Q3
$12.4M Buy
777,405
+533,980
+219% +$8.48M 0.06% 232
2024
Q2
$3.71M Sell
243,425
-55,600
-19% -$847K 0.02% 501
2024
Q1
$4.39M Sell
299,025
-21,525
-7% -$316K 0.02% 464
2023
Q4
$4.46M Sell
320,550
-67,670
-17% -$942K 0.02% 456
2023
Q3
$5.19M Sell
388,220
-124,245
-24% -$1.66M 0.03% 388
2023
Q2
$6.47M Buy
512,465
+159,845
+45% +$2.02M 0.03% 340
2023
Q1
$4.01M Sell
352,620
-474,300
-57% -$5.4M 0.02% 411
2022
Q4
$8.56M Buy
826,920
+285,720
+53% +$2.96M 0.05% 252
2022
Q3
$5.67M Buy
541,200
+12,860
+2% +$135K 0.04% 300
2022
Q2
$5.85M Buy
528,340
+183,945
+53% +$2.04M 0.04% 279
2022
Q1
$3.84M Sell
344,395
-28,155
-8% -$314K 0.02% 371
2021
Q4
$4.87M Buy
372,550
+33,860
+10% +$443K 0.02% 344
2021
Q3
$4.41M Buy
338,690
+103,085
+44% +$1.34M 0.02% 364
2021
Q2
$3.46M Buy
235,605
+6,030
+3% +$88.7K 0.02% 432
2021
Q1
$2.82M Buy
229,575
+163,970
+250% +$2.01M 0.02% 480
2020
Q4
$935K Buy
+65,605
New +$935K 0.01% 639
2020
Q3
Sell
-81,860
Closed -$868K 1089
2020
Q2
$868K Sell
81,860
-68,390
-46% -$725K 0.01% 641
2020
Q1
$1.21M Sell
150,250
-284,000
-65% -$2.29M 0.01% 524
2019
Q4
$3.52M Buy
434,250
+287,750
+196% +$2.34M 0.02% 329
2019
Q3
$1.11M Buy
146,500
+90,500
+162% +$686K 0.01% 525
2019
Q2
$420K Sell
56,000
-11,500
-17% -$86.3K ﹤0.01% 758
2019
Q1
$547K Buy
+67,500
New +$547K ﹤0.01% 651
2018
Q4
Sell
-100,300
Closed -$694K 1034
2018
Q3
$694K Buy
100,300
+37,300
+59% +$258K ﹤0.01% 633
2018
Q2
$406K Buy
+63,000
New +$406K ﹤0.01% 810